Abstract | OBJECTIVE: METHODS: This comparative, nonrandomized, interventional study included 87 patients with uveal melanoma who underwent plaque radiotherapy. The triamcinolone group included 55 consecutive patients who were treated with 40 mg of periocular triamcinolone at the time of plaque application and 4 months and 8 months later. The comparison group comprised 32 consecutive patients treated with plaque radiotherapy without triamcinolone. Patients were evaluated at 4 months, 8 months, 12 months, 18 months, and 24 months after plaque application with clinical examination, fundus photography, and optical coherence tomography (OCT). The associations of clinical variables with the development of OCT-evident macular edema (the main outcome measure) were investigated using Cox proportional hazards analysis. RESULTS: By multivariate analysis, eyes treated with periocular triamcinolone had a significant reduction in the risk of radiation-induced macular edema (P = 0.002; hazard estimate = 0.49; 95% confidence interval, 0.17- 0.80). Adverse effects associated with periocular triamcinolone treatment included elevation of intraocular pressure (7% of cases) and blepharoptosis (5% of cases). CONCLUSIONS:
|
Authors | Noel Horgan, Carol L Shields, Arman Mashayekhi, Luiz F Teixeira, Miguel A Materin, Myra O'Regan, Jerry A Shields |
Journal | Retina (Philadelphia, Pa.)
(Retina)
2008 Jul-Aug
Vol. 28
Issue 7
Pg. 987-95
ISSN: 0275-004X [Print] United States |
PMID | 18698302
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glucocorticoids
- Iodine Radioisotopes
- Triamcinolone Acetonide
|
Topics |
- Brachytherapy
(adverse effects)
- Female
- Glucocorticoids
(adverse effects, therapeutic use)
- Humans
- Injections
- Iodine Radioisotopes
(adverse effects)
- Macula Lutea
(radiation effects)
- Macular Edema
(etiology, prevention & control)
- Male
- Melanoma
(radiotherapy)
- Middle Aged
- Proportional Hazards Models
- Radiation Injuries
(etiology, prevention & control)
- Triamcinolone Acetonide
(adverse effects, therapeutic use)
- Uveal Neoplasms
(radiotherapy)
- Vitreous Body
|